Jiangsu Nanfang Medical Co., Ltd. Class A

Jiangsu Nanfang Medical Co., Ltd. Class A

SSSE:603880
5.98
CNY
-0.48
(-7.43%)
-0.36EPS
2.44BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.38
2.19
2.01
2.06
2.06
1.66
2.29
3.75
1.85
1.86
2.08
2.09
2.07
1.95
Basic EPS, GAAP
0.22
0.25
0.24
0.24
0.2
0.14
0.13
0.34
-0.08
-0.05
-0.51
-0.66
-0.35
-0.37
Free Cash Flow per Basic Share
- -
0.31
0.22
0.21
0.08
-0.09
-0.11
0.11
-1.04
-0.39
-0.18
0.11
0.12
- -
Dividend per Share
0.05
0.09
0.25
0.06
0.2
0.07
0.13
0.06
0.17
0.06
0.07
0.09
0.09
0.08
Book Value per Share
0.79
0.98
1.03
1.18
1.86
1.95
1.98
2.38
2.16
2.11
1.6
0.97
0.61
0.51
Tangible Book Value per Share
0.75
0.83
0.82
0.94
1.66
1.85
1.88
2.25
2.03
1.97
1.47
0.82
0.47
0.38
Basic Weighted Avg Shares
214
215
215
215
238
288
215
286
285
293
289
289
291
287
Sales/Revenue/Turnover
511
470
433
444
489
480
492
1,072
527
545
600
603
601
560
Operating Margin (%)
14.29
16.1
15.57
14.58
12.28
8.13
7.5
14.72
0.85
-2.77
-6.08
-23.53
-9.97
-11.63
Depreciation Expense
- -
8
9
11
11
11
13
20
29
42
55
50
45
- -
Net Income, GAAP
48
53
51
52
48
39
28
98
-23
-15
-147
-191
-102
-106
Effective Tax Rate (%)
15.18
14.69
15.79
15.79
6.53
17.41
10.34
10.56
- -
- -
- -
- -
- -
- -
Profit Margin (%)
9.41
11.36
11.83
11.7
9.74
8.18
5.71
9.14
-4.32
-2.69
-24.57
-31.64
-16.94
-18.88
Working Capital
63
103
82
82
312
337
209
285
3
-129
-222
-340
-341
-362
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
17
- -
21
74
52
Total Equity
169
211
223
257
538
560
568
701
636
621
474
284
181
150
Return on Invested Capital (%)
16.06
15.17
13.65
12.84
8.48
5.37
3.27
11.79
- -
- -
- -
- -
- -
- -
Return on Capital (%)
19.88
17.99
15.33
14.53
10.11
6.73
5.17
13.18
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
33.14
28.24
23.82
21.94
12.13
7.21
5.01
15.55
-3.43
-2.35
-27.15
-50.94
-44.56
-51.04

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
377
373
368
LT Borrowings
67
60
52
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
289
289
289
Market Capitalization
2,038
2,041
2,442

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
317
287
275
Cash, Cash Equivalents & STI
65
58
42
Accounts Receivable, Net
120
92
90
Inventories
114
123
127
Total Current Liabilities
660
643
637
Payables & Accruals
- -
- -
- -
ST Debt
377
373
368
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.22%
-22.31%
-36.3%
Free Cash Flow
-186.55%
-265.31%
11.71%
Net Income, GAAP
92.67%
146.04%
-46.66%
Sales/Revenue/Turnover
9.4%
-7.46%
-0.35%
Total Cash Common Dividend
26.82%
34.82%
-4.34%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
139
163
153
148
603
2025
171
135
- -
153
601
2026
155
116
136
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
-0.05
-0.61
-0.66
2025
-0.03
-0.02
- -
-0.27
-0.35
2026
-0.02
-0.04
-0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
0.01
0.07
0.09
2025
0.02
0.03
- -
0.03
0.09
2026
0.02
0.02
0.02
- -
- -

Company Description

CEO
Ling Feng He
Full Time Employees
789
Sector
Health technology
Industry
Medical specialties
Address
1 Guoxiang Road Changzhou JS China 213149
IPO Date
Aug 7, 2017
Business
Jiangsu Nanfang Medical Co., Ltd. (603880.SS) engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, first-aid kits, sports protection products, protective equipment, and nursing products. The company offers specific items including medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, masks, medical nitrile examination gloves, and disposable medical masks; its main brands include Miaoshou for tapes and plasters, and Nanwei for analgesic and corn plasters. Products are sold to pharmaceutical companies, hospitals, and end-users in China and internationally across more than 20 countries in Europe, America, Africa, Southeast Asia, and South Africa. Founded in 1990 as Changzhou Nanfang Medical Appliance Factory Co., Ltd. and restructured into its current shareholding form on October 31, 2012, the company is headquartered at No. 1 Guoxiang Road, Wujin Economic Development Zone, Changzhou, Jiangsu Province, China. In recent developments, the company applied for a military science and technology progress award in June 2024, demonstrating advancements in its product technologies amid ongoing emphasis on research and engineering capabilities. It maintains eight automated production lines with annual capacity exceeding 40 million rolls of medical tapes and 2 billion pieces of wound plasters, supporting steady operational expansion.